Annual report
6894.TEDINET S100YDWK
Period2025-04-01 → 2026-03-31
Filed2026-06-18
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥357m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥336m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥396m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥354m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥387m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥333m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥352m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥396m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥340m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥286m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥356m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥327m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥243m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥340m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥286m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥356m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥5.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥5.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.5bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.0bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.7bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.2bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥583m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥153m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥399m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥105m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥659m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥598m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥375m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥89m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥24m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥66m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥154m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥159m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥146m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥226m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥72m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥208.9 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥260.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.99 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.53 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.75 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,930.63 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,823.85 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,685.76 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,497.84 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,392.34 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 79.9% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.9% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.6% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.9% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 123 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 124 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 128 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 134 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 134 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥2.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥2.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥347m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥342m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥383m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥357m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥377m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥328m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥342m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥383m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥343m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥276m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥360m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥319m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥241m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥331m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥5.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥5.1bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥997m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.6bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥201.87 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥263.08 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.87 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥175.86 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.58 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥85 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥110 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥110 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,895.44 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,800.73 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,658.93 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,484.83 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,385.25 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.8% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.1% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,393,459 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 122 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 123 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 127 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 133 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 133 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Healthcare Related Productsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥4m |
| Healthcare Related Productsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥8m |
| Healthcare Related Productsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥627m |
| Healthcare Related Productsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥627m |
| Healthcare Related Productsreportable segment | segment assets | at 2026-03-31 | ¥461m |
| Healthcare Related Productsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥18m |
| Optical Applications And Special Customized Productsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥21m |
| Optical Applications And Special Customized Productsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥44m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.0bn |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.0bn |
| Optical Applications And Special Customized Productsreportable segment | segment assets | at 2026-03-31 | ¥950m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥329m |
| X Ray Residual Stress Analyzerreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥43m |
| X Ray Residual Stress Analyzerreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥20m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥893m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥893m |
| X Ray Residual Stress Analyzerreportable segment | segment assets | at 2026-03-31 | ¥366m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥347m |
| —segment total | employees | at 2026-03-31 | 107 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥68m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥72m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥658m |
| Healthcare Related Productsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2m |
| Healthcare Related Productsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥7m |
| Healthcare Related Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥711m |
| Healthcare Related Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥711m |
| Healthcare Related Productsreportable segment | segment assets | at 2025-03-31 | ¥427m |
| Healthcare Related Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥40m |
| Optical Applications And Special Customized Productsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥487m |
| Optical Applications And Special Customized Productsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥23m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥936m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥936m |
| Optical Applications And Special Customized Productsreportable segment | segment assets | at 2025-03-31 | ¥1.1bn |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥259m |
| X Ray Residual Stress Analyzerreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥28m |
| X Ray Residual Stress Analyzerreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥10m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥839m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥839m |
| X Ray Residual Stress Analyzerreportable segment | segment assets | at 2025-03-31 | ¥415m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥363m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥518m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥40m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥662m |
| —segment total | employees | at 2026-03-31 | 106 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,223
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 123 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 122 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 23 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 21 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 22 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 29 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 28 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.971 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.919 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.202 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.193 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.463 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.020 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.079 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.525 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.502 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 2.022 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 90 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 99.1 | |
| Research and development expenses research and development activities | CurrentYearDuration | 29000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 124000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 43000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 3000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 20000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 56000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1393459 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1393459 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1393459 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1393459 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 2 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 19 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 24 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 17 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 2 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 1689 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 1753 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 138 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 266 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 1168 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 248 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 6 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 11971 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 13797 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 13759 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0100 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0193 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |